Red light therapy is a category with two evidence bases, and the trend has mixed them up. Photobiomodulation, the clinical name for exposing tissue to red and near-infrared light, has randomised trial support for hair regrowth in pattern baldness, for some measures of skin ageing, and for wound healing. Those are the uses regulators have cleared devices for, and a 2025 meta-analysis confirmed meaningful hair-density improvements at 16 to 24 weeks.
The uses a screen worker buys a panel for are different: better sleep, sharper eyes, recovery, focus. There the evidence is thin in a specific way. The most-cited sleep study enrolled 20 elite basketball players and gave its control group no light at all, so nobody was blinded. The eyesight claim rests on small studies from one laboratory, and the 12-month pilot that tried to extend it to people with retinal disease found no effect. Searches for red light therapy masks run at 201,000 a month, up 172 per cent year on year, and almost all of that demand is for the second set of claims.
What the light does

Red light in the 630 to 660 nanometre range and near-infrared around 810 to 850 penetrates skin and is absorbed by an enzyme in mitochondria, cytochrome c oxidase, which is proposed to increase energy production in the cell. That mechanism is well studied in the laboratory and is the basis for the wound and hair applications, where the target tissue is close to the surface and the outcome is measurable.
The further the claim travels from the skin, the less the mechanism helps. Whether light on the chest changes sleep, or light in the eye changes vision, are questions the mechanism does not settle and only trials can.
The sleep evidence

The study behind almost every sleep claim was published in the Journal of Athletic Training in 2012. Twenty elite female basketball players in China were divided into a red light group, which received 30 minutes of whole-body irradiation every night for 14 days, and a placebo group. The abstract states the control condition in one sentence: the placebo group did not receive light illumination.
That is the flaw. A trial in which one group lies under a glowing panel for half an hour nightly and the other does nothing cannot separate the light from the ritual, the rest, or the expectation. Sleep quality was measured by questionnaire, and serum melatonin rose in the treatment group with a correlation between the two, which is the finding that travels. Twelve-minute run performance also improved, which is the finding athletic trainers cite. Twenty people, two weeks, no sham, one population.
Reviewers writing for device retailers concede this. One describes the study as compelling and then lists the limitations: small sample, specific population, no replication in a broader population. Another notes that elite athletes under heavy training stress may respond differently from the average person. The same sources add that a 2019 study found red light reduced insomnia severity in patients with chronic low back pain, which is plausibly a pain effect rather than a sleep effect, and cite a 2026 randomised trial in older adults with insomnia that is too recent to have been independently assessed.
One thing about red light and sleep is well established and is not a therapy claim: red and amber light does not suppress melatonin the way blue light does, so a red bulb is a better evening light than a white one. That is a lighting choice, not a treatment, and the site’s coverage of dark mode and eye strain makes the related point about screens. It does not require a panel.
The eyesight evidence

The claim that a few minutes of red light in the morning improves ageing vision comes from a research group at University College London. Its 2021 study in Scientific Reports found that a single three-minute exposure to 670 nanometre light in the morning improved colour contrast sensitivity in older adults, with no effect at midday. The numbers are small, the effect is on one measure of vision, and the timing dependence is the kind of finding that needs replication before it becomes advice.
The attempt to extend the finding to disease is instructive. A pilot study gave daily morning 670 nanometre light to 31 patients with intermediate age-related macular degeneration and 11 healthy older people for 12 months. In healthy eyes there was a small improvement in one dark-adaptation measure and no other clinically significant change. In eyes with intermediate disease there was no significant improvement in any functional or structural measure at any time point up to 12 months, despite good compliance. The authors’ conclusion: photobiomodulation at this wavelength has no effect in patients who have already progressed to intermediate disease.
For a screen worker, the relevant reading is that the eyesight claim is a small effect on contrast sensitivity in healthy older eyes, from one group, on a timing that has not been independently confirmed. It is not a treatment for eye strain, dry eye or any diagnosed condition, and the disease trial was negative.
What is actually supported

The honest list is short and does not involve a desk. Androgenetic alopecia: a 2025 systematic review and meta-analysis confirmed hair-density improvements, and a 2017 analysis found low-level laser therapy, minoxidil and finasteride each beat placebo. Wound healing, including diabetic foot ulcers: a consistent body of trial evidence, with a 2024 randomised trial showing meaningful wound closure. Skin ageing: some randomised support. Direct retinal exposure from panels is the main safety risk and goggles are standard for that reason, which sits oddly beside the eyesight trend.
Everything on that list is a surface tissue with a measurable outcome. Nothing on it is sleep, focus, energy or recovery.
What this connects to

This site has covered the one form of light therapy with strong clinical evidence, light therapy lamps for winter low mood, where bright white light has decades of randomised trials for seasonal depression. Red light is not that. The wavelength, the mechanism and the evidence are different, and the two are often sold on the same shelf.
The pattern here resembles grounding sheets, a plausible physical mechanism carried far beyond what has been tested, though red light has a much stronger base for its real uses. And as with brown noise for sleep, the sleep claim rests on a study that could not blind its participants.
Where this belongs with a clinician
Persistent insomnia has causes a panel does not address, and the treatment with strong evidence is a structured therapy, not a light. Changes in vision, including trouble with contrast or night vision, need an optometrist or ophthalmologist, because the conditions that cause them are diagnosed and treated, and the eyesight trial above was negative for the one disease it tested. Anyone with a photosensitising medication, an eye condition, or a history of skin cancer should ask a doctor before regular light exposure.
This article prescribes no wavelength, dose, distance or duration. The trials used clinical devices at specified settings that do not map onto a mask bought online.
Common questions
Does red light therapy help you sleep?
The evidence is one small unblinded trial. In 2012, 20 elite female basketball players received 30 minutes of red light nightly for 14 days; the control group received no light at all, so participants knew their condition. Questionnaire sleep scores and serum melatonin improved in the light group. No sham-controlled replication in a general population exists. Red light not suppressing melatonin the way blue light does is well established, but that is a lighting choice, not a therapy.
Does red light improve eyesight?
One laboratory group reported that a three-minute morning exposure to 670 nanometre light improved colour contrast sensitivity in older adults, with no effect at midday. A 12-month pilot extending this to 31 patients with intermediate macular degeneration found no significant functional or structural improvement at any time point. The healthy-eye effect is small, on one measure, and unreplicated by other groups. Vision changes need an eye specialist.
What is red light therapy actually proven for?
Hair regrowth in pattern baldness, where a 2025 meta-analysis confirmed density improvements and devices are regulator-cleared; wound healing, including diabetic foot ulcers; and some measures of skin ageing. These are surface tissues with measurable outcomes and randomised trials. Sleep, focus, energy and recovery are not on that list.
Is red light therapy safe?
Direct retinal exposure is the main risk and goggles are standard with panels. People on photosensitising medications, with eye conditions, or with a history of skin cancer should ask a doctor first. The trials used clinical devices at specified settings; consumer masks vary, and this article recommends none.
Real science, borrowed for the wrong claims
Red light therapy is not grounding sheets. It has a mechanism that works in the laboratory, trials that work on skin and hair, and regulatory clearances for those uses. That is more than most things on this site can say.
The problem is what the trend is selling. The sleep evidence is twenty athletes and no sham. The eyesight evidence is one group, one measure, and a negative disease trial. The focus and energy claims have nothing at all. A category with real evidence has been marketed on the claims it has least of, and the searches follow the marketing.
Did this answer your question?
Thanks. That helps us decide what to fix.




Leave a comment